Stockreport

Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]

Reviva Pharmaceuticals Holdings, Inc.  (RVPH) 
PDF - Current data package highlights well-tolerated long-term safety profile, broad-spectrum clinical activity, and favorable adherence for once daily brilaroxazine up to [Read more]